Intuitive Surgical (ISRG) VP executes 10b5-1 stock sales after RSU vest
Rhea-AI Filing Summary
Intuitive Surgical VP Corporate Controller Fredrik Widman reported planned share sales and RSU vesting activity. He sold 249 shares of common stock on February 27, 2026 at $499.71 per share, and 118 shares on March 3, 2026 at $487.18 per share in open-market transactions under a Rule 10b5-1 trading plan that runs through May 21, 2026.
These sales followed the vesting of 468 restricted stock units on February 28, 2026, which converted into the same number of common shares. To cover statutory tax withholding on the vesting, 233 shares of common stock were disposed of at $503.51 per share. After these transactions, Widman directly held just over one thousand common shares.
Positive
- None.
Negative
- None.
Insights
Planned, small insider net selling tied to RSU vesting.
The filing shows Fredrik Widman executing a mix of equity compensation events and modest open-market sales. 468 RSUs vested and converted into common stock, with 233 shares withheld to satisfy tax obligations, which is typical for stock-based awards.
Subsequently, Widman sold 249 shares at $499.71 and 118 shares at $487.18 under a pre-arranged Rule 10b5-1 trading plan that is scheduled to expire on May 21, 2026. The plan-based nature and relatively small share counts point to routine portfolio and tax management rather than a thesis-changing move.
The net result is a reduction of a few hundred shares, leaving him with a remaining direct stake in Intuitive Surgical common stock. Future company filings may provide additional context on ongoing equity grants, vesting schedules, or further transactions under the same trading plan.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 118 | $487.18 | $57K |
| Exercise | Restricted Stock Units | 468 | $0.00 | -- |
| Exercise | Common Stock | 468 | $0.00 | -- |
| Tax Withholding | Common Stock | 233 | $503.51 | $117K |
| Sale | Common Stock | 249 | $499.71 | $124K |
Footnotes (1)
- The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 21, 2026. RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25% of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account. Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period.